With a completely new method of treatment, scientists have managed to successfully shrink a deadly cancerous tumor from a patient's head, using a magnetic helmet.
The news published in a foreign newsgraphics sites impressed us, as wherever we hear magnetic 'devices healths' we think they are total garbage that you shouldn't waste your money on. But scientists from Houston, USA, challenged this general rule by putting a magnetic helmet on a patient's head that significantly shrunk a deadly brain tumor without any invasive surgery. All from the comfort of the patient's home.
Η this study was started with one patient to suffer from glioblastoma, the most deadly of brain cancers. The patient has already undergone standard and extreme treatments, including radical surgical removal, chemoradiotherapy and experimental gene therapy, and unfortunately, none of them have been successful in his condition.
Through an FDA-approved process known as palliative-use therapy, the researchers attempted a new method using oscillating magnetic fields. The patient wore a helmet with rotating permanent magnets, with the oscillating magnetic fields created in specific frequency profiles and timing patterns.
At first, the patient wore the helmet for two hours under the supervision of a specialist, before moving home and wearing it for up to six hours with the help of womanhis. For the record, unfortunately, the patient died of an unrelated injury about a month after treatment. But his death allowed scientists to get a closer look Results.
The family generously allowed the researchers to do an autopsy to see first hand how well the treatment worked. And as it turned out, the volume shrank by 31%. Given that the result came without surgery or chemotherapy, future applications of this technology are promising.
But as with most medical discoveries, more tests are needed, along with repetitive results. However, if scientists can replicate the results successfully, this could lead to a new and less invasive treatment for some of the worst cancers.